Opinion: Buy This Growth Stock to Beat the S&P 500 in 2027
This artificial intelligence cloud stock could be the ticket to market-crushing returns next year.
·
The Motley Fool
Bristol Myers Squibb’s Growth Portfolio Now Brings In $7.7 Billion a Quarter. Here’s Why That Changes the Stock’s Story.
Bristol Myers Squibb is facing down the expiration of patent protections for older drugs, but new drugs are starting to show promise.
·
The Motley Fool
Cisco Just Raised Its AI Forecast Again. Is it a Buy?
The networking giant's AI business is growing much faster than its valuation suggests.
·
The Motley Fool
The Blockchain Boom Is Still Happening Behind the Scenes. These 3 Growth Stocks Will Benefit.
Blockchain is being used silently in key products and services that people use. It's good for these three stocks.
·
The Motley Fool
4 Dividend Stocks Yielding 4% or More to Buy Before the End of November
High yields from reliable dividend payers are what you'll get if you buy Realty Income, Federal Realty, PepsiCo, and Hormel.
·
The Motley Fool
Regeneron Has $16 Billion in Net Cash and Trades Near 20 Times Earnings. Is It the Cheapest Big Biotech?
The stock has climbed more than 40% in one year.
·
The Motley Fool
Why a Rising TSMC Challenger Could Reshape the Chip Foundry Landscape
Japan's state-backed Rapidus is promising cheaper 2-nanometer chips, but it still has to prove that it can manufacture them.
·
The Motley Fool